HHS 宣布利用 AI 加速并扩大临床试验的新举措
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
美国卫生与公众服务部(HHS)宣布启动一系列新计划,旨在通过引入人工智能和计算模型、打破严格划分的试验阶段来加速临床试验。核心项目为为期五年的“SURPASS”(模拟增强、实时平台自适应无缝试验),由医疗先进技术计划局启动,计划于今年秋季接受来自统计学、AI 及临床试验设计等跨学科团队的创新想法。公告未披露该计划的具体资金规模或是否提供更灵活的资源支持。
WASHINGTON — The Department of Health and Human Services announced a set of new initiatives aimed at speeding up clinical trials by incorporating more artificial intelligence and computational models and moving away from sharply delineated trial phases.
The centerpiece five-year program, dubbed SURPASS — “Simulation-augmented, Real-time Platform Adaptive Seamless Trials” — will kick off later this fall by accepting “ground-breaking ideas from cross-disciplinary teams in statistics, AI, and clinical trial design, operations, and regulation,” reads a website about the program.
HHS is launching the program through the Advanced Research Projects Agency for Health. The initial announcement did not note how much funding was designated for the new initiatives, nor did it provide details on whether participants would be offered more flexibility or resources.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT Pharma 医药频道 · statnews.com